Functional genomics training in-house
The African Centre for Vector Genomics (AVecGen) is a transformative, 36-month initiative designed to establish Africa’s premier centre of excellence in vector genomics. Anchored at the Centre for Research in Infectious Diseases (CRID) in Cameroon, AVecGen will feature cutting-edge genomics and bioinformatics infrastructure, positioning CRID as the continent’s leading regional reference hub for malaria vector research and innovation. This ambitious project is made possible through a $5.56 million investment from the Bill & Melinda Gates Foundation, with strategic partnerships involving the Liverpool School of Tropical Medicine (LSTM) and the Malaria Genomic Epidemiology Network (MalariaGEN).
AVecGen’s vision extends far beyond infrastructure. The project is committed to revolutionising capacity building across Africa by decentralising and democratising access to advanced genomic and bioinformatics expertise. Through intensive, hands-on training programmes, AVecGen will empower a new generation of African scientists with world-class skills in both laboratory and computational sciences. These efforts will catalyse local leadership in critical research areas such as insecticide resistance, tracking invasive vector species, understanding vector competence, and evaluating the impact of innovative interventions.
Launched in October 2024 and scheduled for completion in September 2027, AVecGen will ensure that African researchers are at the forefront of vector genomics, driving sustainable, evidence-based strategies for malaria elimination. The project is led by Prof. Charles Wondji (Principal Investigator), supported by a multidisciplinary team of experts in capacity building, bioinformatics, sequencing, functional genomics, and project management based at CRID. AVecGen represents a bold step towards scientific self-reliance and leadership in Africa’s fight against malaria.
